|1.||Sato, Yoshihiro: 6 articles (12/2011 - 01/2005)|
|2.||Iwamoto, Jun: 6 articles (12/2011 - 01/2005)|
|3.||Thacher, Tom D: 5 articles (09/2014 - 12/2006)|
|4.||Singh, Rakesh K: 4 articles (11/2013 - 01/2011)|
|5.||Brard, Laurent: 4 articles (11/2013 - 01/2011)|
|6.||Kanoko, Tomohiro: 4 articles (07/2006 - 01/2005)|
|7.||Satoh, Kei: 4 articles (07/2006 - 01/2005)|
|8.||Pettifor, John M: 3 articles (09/2014 - 12/2006)|
|9.||Fischer, Philip R: 3 articles (09/2014 - 12/2006)|
|10.||Kalantar-Zadeh, Kamyar: 3 articles (03/2014 - 09/2009)|
|1.||Vitamin D Deficiency
12/01/1996 - "To determine the efficacy of a single oral dose of 150,000 IU of vitamin D2 at the beginning of autumn for preventing winter vitamin D deficiency in children in Ushuaia (55 degrees S). "
01/01/2015 - " studies compared ergocalciferol in patients with CKD and vitamin D deficiency. "
07/15/2005 - "The results of this study demonstrate that a majority of adults with CF have serum 25-OHD levels below 30 ng/ml, and the currently recommended ergocalciferol repletion regimen often does not fully correct vitamin D deficiency and may need to be revised to include even higher dosing of ergocalciferol. "
10/01/2015 - "Vitamin D deficiency or insufficiency is an independent risk factor for VAD in HD patients; its treatment with ergocalciferol is associated with decreased VAD. "
01/01/2015 - "Effects of a 10-day course of a high dose calciferol versus a single mega dose of ergocalciferol in correcting vitamin D deficiency."
11/01/1987 - "Both patients were treated with very large doses of vitamin D2 and phosphate without improvement in the osteomalacia or normalization of the serum phosphate. "
04/01/1982 - "The efficacy of vitamin D2 in the dose of 2000 IU daily in reversing anticonvulsant osteomalacia was studied in nine epileptic inpatients. "
01/01/1984 - "A possible role of vitamin D2 in producing osteomalacia is not easy to understand since normal serum levels of 25(OH)-D2, the circulating form of vitamin D2, have been reported. "
08/01/1978 - "Ca infusion (1500 mg/m2/12 h) induced an increase in serum P level to 3.2 mg/100 ml, in tubular phosphate reabsorption from 72 to 90%, while serum iPTH decreased to 33 micron1Eq/ml. Vitamin D2 administration (45 mg) resulted in increased 25-OHCC concentration to 28 ng/ml and in healing of pelvic osteomalacia. "
01/01/1977 - "Effect of long-term vitamin D2 treatment on bone morphometry and biochemical values in anticonvulsant osteomalacia."
01/01/1975 - "Severe rickets which had not responded to large amounts (greater than 200 mg in total) of vitamin D2 was markedly cured with 2.5 mug of 1alpha-OH-D3 given daily for 3 weeks. "
09/01/2010 - "We administered an oral single dose of vitamin D(2) or D(3) of 1.25 mg to 49 Nigerian children--28 with active rickets and 21 healthy controls. "
12/01/2006 - "We administered vitamin D(2), 50,000 IU orally to 16 Nigerian children 15 to 48 months of age with radiographically active rickets. "
09/01/2000 - "once) at 4 mo of age, followed by oral supplementation of 400 IU vitamin D2 daily until weaning, prevents rickets in juvenile chimpanzees raised indoors."
07/01/1981 - "Mild morphological lesions of rickets developed in several boars not receiving supplemental vitamin D2 and in boars supplemented with 100 an 300 IU/kg of feed."
|4.||Cystic Fibrosis (Mucoviscidosis)
03/01/2010 - "Transient effectiveness of vitamin D2 therapy in pediatric cystic fibrosis patients."
03/01/2001 - "Diminished and erratic absorption of ergocalciferol in adult cystic fibrosis patients."
07/01/2009 - "Very high-dose ergocalciferol is effective for correcting vitamin D deficiency in children and young adults with cystic fibrosis."
07/15/2005 - "Failure of high-dose ergocalciferol to correct vitamin D deficiency in adults with cystic fibrosis."
10/01/2008 - "To determine the prevalence of vitamin D deficiency (25-hydroxy vitamin D [25-OHD] levels in plasma <30 ng/mL) in pediatric patients with cystic fibrosis (CF), elucidate contributing factors for vitamin D deficiency, and determine the efficacy of ergocalciferol repletion strategies. "
|5.||Kidney Diseases (Kidney Disease)
01/01/2013 - "Our aim was to evaluate the efficacy of prescribing ergocalciferol supplementation based on KDOQI guidelines for chronic kidney disease (CKD) stages III-IV in HD patients. "
03/01/2013 - "Ergocalciferol treatment and aspects of mineral homeostasis in patients with chronic kidney disease stage 4-5."
01/01/2013 - "An ergocalciferol-prescribing strategy using the KDOQI guidelines for stage III-IV kidney disease in HD patients with VitD deficiency or insufficiency is inadequate to achieve repletion or maintenance of normal VitD levels."
02/01/2012 - "Ergocalciferol (or a matched placebo) was given daily as per Kidney Disease Outcomes Quality Initiative guidelines. "
01/01/2014 - "Ergocalciferol improved microcirculatory endothelial function in patients with chronic kidney disease and concomitant vitamin D deficiency. "
|2.||Cholecalciferol (Vitamin D3)
|1.||Renal Dialysis (Hemodialysis)
|4.||Heterologous Transplantation (Xenotransplantation)